다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Molecular aspects of medicine, v.58, 2017년, pp.102 - 113
Brennan, E.P. , Cacace, A. , Godson, C.
AI-Helper
Inflammation and its timely resolution play a critical role in effective host defence and wound healing. Unresolved inflammatory responses underlie the pathology of many prevalent diseases resulting in tissue fibrosis and eventual organ failure as typified by kidney, lung and liver fibrosis. The rol...
Am. J. physiology An 297 4 F895 2009 Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney
Hepatology Andersson 49 5 Suppl. l S166 2009 10.1002/hep.22899 Monitoring during and after antiviral therapy for hepatitis B
J. cell Sci. Annes 116 Pt 2 217 2003 10.1242/jcs.00229 Making sense of latent TGFbeta activation
Proc. Natl. Acad. Sci. U. S. A. Arita 102 21 7671 2005 10.1073/pnas.0409271102 Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis
Mucosal Immunol. Arnardottir 9 3 757 2016 10.1038/mi.2015.99 Human milk proresolving mediators stimulate resolution of acute inflammation
J. Immunol. Baker 182 6 3819 2009 10.4049/jimmunol.0803175 Lipoxin A4: anti-inflammatory and anti-angiogenic impact on endothelial cells
Immunology Basil 16 1 51 2016 Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. Nature reviews
Nat. Med. Bechtel 16 5 544 2010 10.1038/nm.2135 Methylation determines fibroblast activation and fibrogenesis in the kidney
BMC Med. genomics Bell 3 33 2010 10.1186/1755-8794-3-33 Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus
Diabetes Berthier 58 2 469 2009 10.2337/db08-1328 Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy
J. Am. Soc. Nephrol. Bienaime 27 12 3690 2016 10.1681/ASN.2015091014 Stat3 controls tubulointerstitial communication during CKD
Faseb J. Borgeson 25 9 2967 2011 10.1096/fj.11-185017 Lipoxin A(4) and benzo-lipoxin A(4) attenuate experimental renal fibrosis
Cell Metab. Borgeson 22 1 125 2015 10.1016/j.cmet.2015.05.003 Lipoxin A4 attenuates obesity-induced adipose inflammation and associated liver and kidney disease
Kidney Int. Bowden 66 4 1517 2004 10.1111/j.1523-1755.2004.00915.x A genome scan for diabetic nephropathy in African Americans
Trends cell Biol. Brazil 25 5 249 2015 10.1016/j.tcb.2014.12.004 BMP signalling: agony and antagony in the family
Biochimica biophysica acta Brennan 1822 4 589 2012 10.1016/j.bbadis.2012.01.008 Next-generation sequencing identifies TGF-beta1-associated gene expression profiles in renal epithelial cells reiterated in human diabetic nephropathy
J. Am. Soc. Nephrol. Brennan 24 4 627 2013 10.1681/ASN.2012060550 Lipoxins attenuate renal fibrosis by inducing let-7c and suppressing TGFbetaR1
Curr. Opin. Nephrol. Hypertens. Brosius 24 1 88 2015 10.1097/MNH.0000000000000079 JAK inhibition and progressive kidney disease
Lung Cell. Mol. physiology Buchanan 305 2 L193 2013 10.1152/ajplung.00058.2013 Lipoxin A(4)-mediated KATP potassium channel activation results in cystic fibrosis airway epithelial repair. American journal of physiology
Cell Tissue Res. Carew 347 1 103 2012 10.1007/s00441-011-1227-1 The role of EMT in renal fibrosis
Nat. Chem. Biol. Chen 6 6 401 2010 10.1038/nchembio.375 COX-2's new role in inflammation
Immunopharmacol. Immunotoxicol. Chen 38 2 61 2016 10.3109/08923973.2015.1115517 Resolvin D1 attenuates CCl4-induced acute liver injury involving up-regulation of HO-1 in mice
J. Exp. Med. Chiang 212 8 1203 2015 10.1084/jem.20150225 Identification of resolvin D2 receptor mediating resolution of infections and organ protection
Nature Chiang 484 7395 524 2012 10.1038/nature11042 Infection regulates pro-resolving mediators that lower antibiotic requirements
J. Immunol. Claria 189 5 2597 2012 10.4049/jimmunol.1201272 Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat
Proc. Natl. Acad. Sci. U. S. A. Claria 92 21 9475 1995 10.1073/pnas.92.21.9475 Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions
Gastroenterology Claria 115 1 147 1998 10.1016/S0016-5085(98)70376-2 Altered biosynthesis of leukotrienes and lipoxins and host defense disorders in patients with cirrhosis and ascites
Cell physiol. Colas 307 1 C39 2014 10.1152/ajpcell.00024.2014 Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue. American journal of physiology
Nat. Med. Connor 13 7 868 2007 10.1038/nm1591 Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis
Proc. Natl. Acad. Sci. U. S. A. Cooray 110 45 18232 2013 10.1073/pnas.1308253110 Ligand-specific conformational change of the G-protein-coupled receptor ALX/FPR2 determines proresolving functional responses
Expert Opin. Pharmacother. Cravedi 11 16 2651 2010 10.1517/14656566.2010.521742 Which antihypertensive drugs are the most nephroprotective and why?
Blood Dalli 120 15 e60 2012 10.1182/blood-2012-04-423525 Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators
FASEB J. official Publ. Fed. Am. Soc. Exp. Biol. Dalli 27 7 2573 2013 The novel 13S,14S-epoxy-maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H), and shifts macrophage phenotype
J. Am. Soc. Nephrol. JASN de Boer 25 10 2342 2014 10.1681/ASN.2013091004 Renal outcomes in patients with type 1 diabetes and macroalbuminuria
Am. J. kidney Dis. official J. Natl. Kidney Found. Dolan 45 6 1034 2005 10.1053/j.ajkd.2005.03.014 Expression of gremlin, a bone morphogenetic protein antagonist, in human diabetic nephropathy
J. Clin. investigation Duffield 124 6 2299 2014 10.1172/JCI72267 Cellular and molecular mechanisms in kidney fibrosis
J. Am. Soc. Nephrol. Duffield 27 12 3502 2016 10.1681/ASN.2016060603 Beyond EMT: epithelial STAT3 as a central regulator of fibrogenesis
J. Immunol. Duffield 177 9 5902 2006 10.4049/jimmunol.177.9.5902 Resolvin D series and protectin D1 mitigate acute kidney injury
PloS one Eickmeier 12 2 e0171249 2017 10.1371/journal.pone.0171249 Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis
Proc. Natl. Acad. Sci. U. S. A. El Kebir 109 37 14983 2012 10.1073/pnas.1206641109 Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation
Diabetes Elias 65 8 2139 2016 10.2337/db16-0040 ALOX5AP overexpression in adipose tissue leads to LXA4 production and protection against diet-induced obesity and insulin resistance
Seminars Nephrol. Ferenbach 27 3 250 2007 10.1016/j.semnephrol.2007.02.001 Inflammatory cells in renal injury and repair
J. Pharmacol. Exp. Ther. Fierro 300 2 385 2002 10.1124/jpet.300.2.385 Novel lipid mediator regulators of endothelial cell proliferation and migration: aspirin-triggered-15R-lipoxin A(4) and lipoxin A(4)
Proc. Natl. Acad. Sci. U. S. A. Fiorucci 101 44 15736 2004 10.1073/pnas.0404722101 A beta-oxidation-resistant lipoxin A4 analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction
Physiol. Rev. Forbes 93 1 137 2013 10.1152/physrev.00045.2011 Mechanisms of diabetic complications
Nat. Commun. Fredman 7 12859 2016 10.1038/ncomms12859 An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques
Nat. Rev. Drug Discov. Fullerton 15 8 551 2016 10.1038/nrd.2016.39 Resolution of inflammation: a new therapeutic frontier
J. diabetes Res. Gao 589474 2013 Impact of high glucose and proteasome inhibitor MG132 on histone H2A and H2B ubiquitination in rat glomerular mesangial cells
Dis. models Mech. Giannandrea 7 2 193 2014 10.1242/dmm.012062 Diverse functions of matrix metalloproteinases during fibrosis
J. Immunol. Godson 164 4 1663 2000 10.4049/jimmunol.164.4.1663 Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages
Nat. Med. Grande 21 9 989 2015 10.1038/nm.3901 Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease
N. Engl. J. Med. Gregg 370 16 1514 2014 10.1056/NEJMoa1310799 Changes in diabetes-related complications in the United States, 1990-2010
Diabetes Groop 58 7 1651 2009 10.2337/db08-1543 The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes
Am. J. Respir. cell Mol. Biol. Guilherme 49 6 1029 2013 10.1165/rcmb.2012-0462OC Pulmonary antifibrotic mechanisms aspirin-triggered lipoxin A(4) synthetic analog
Faseb J. Hasturk 20 2 401 2006 10.1096/fj.05-4724fje RvE1 protects from local inflammation and osteoclast- mediated bone destruction in periodontitis
Faseb J. Hellmann 25 7 2399 2011 10.1096/fj.10-178657 Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice
Am. J. Pathol. Humphreys 176 1 85 2010 10.2353/ajpath.2010.090517 Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis
Kidney Int. Ito 53 4 853 1998 10.1111/j.1523-1755.1998.00820.x Expression of connective tissue growth factor in human renal fibrosis
J. Clin. Invest Iwano 110 3 341 2002 10.1172/JCI0215518 Evidence that fibroblasts derive from epithelium during tissue fibrosis
Lancet Jha 382 9888 260 2013 10.1016/S0140-6736(13)60687-X Chronic kidney disease: global dimension and perspectives
J. lipid Res. Jones 54 8 2247 2013 10.1194/jlr.M039842 Maternal dietary omega-3 fatty acid intake increases resolvin and protectin levels in the rat placenta
Sci. Transl. Med. Ju 7 316 316ra193 2015 10.1126/scitranslmed.aac7071 Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker
J. Clin. Invest Kalluri 112 12 1776 2003 10.1172/JCI200320530 Epithelial-mesenchymal transition and its implications for fibrosis
Nat. Genet. Kao 40 10 1185 2008 10.1038/ng.232 MYH9 is associated with nondiabetic end-stage renal disease in African Americans
Nat. Immunol. Karp 5 4 388 2004 10.1038/ni1056 Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway
Front. physiology Ke 8 21 2017 Matrix Metalloproteinases-7 and kidney fibrosis
Kidney Int. Kieran 64 2 480 2003 10.1046/j.1523-1755.2003.00106.x Modification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analog
Kidney Int. Kim 64 5 1715 2003 10.1046/j.1523-1755.2003.00288.x Activation of the TGF-beta/Smad signaling pathway in focal segmental glomerulosclerosis
Nat. Genet. Kottgen 41 6 712 2009 10.1038/ng.377 Multiple loci associated with indices of renal function and chronic kidney disease
J. Am. Soc. Nephrol. Kottgen 19 10 1989 2008 10.1681/ASN.2007121291 TCF7L2 variants associate with CKD progression and renal function in population-based cohorts
10.1073/pnas.0907342107 Krishnamoorthy, S., Recchiuti, A., Chiang, N., Yacoubian, S., Lee, C.H., Yang, R., Petasis, N.A., Serhan, C.N., Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc Natl Acad Sci U S A 107(4), 1660-1665.
Nat. Med. LeBleu 19 8 1047 2013 10.1038/nm.3218 Origin and function of myofibroblasts in kidney fibrosis
J. Biol. Chem. Lee 292 2 732 2017 10.1074/jbc.M116.753822 Absence of miR-146a in podocytes increases risk of diabetic glomerulopathy via up-regulation of ErbB4 and Notch-1
J. Am. Soc. Nephrol. JASN Leonard 13 6 1657 2002 10.1097/01.ASN.0000015795.74094.91 15-Epi-16-(para-fluorophenoxy)-lipoxin A(4)-methyl ester, a synthetic analogue of 15-epi-lipoxin A(4), is protective in experimental ischemic acute renal failure
Am. J. Respir. Crit. care Med. Levy 172 7 824 2005 10.1164/rccm.200410-1413OC Diminished lipoxin biosynthesis in severe asthma
J. Immunol. Levy 178 1 496 2007 10.4049/jimmunol.178.1.496 Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness
Sci. Rep. Li 7 39487 2017 10.1038/srep39487 Novel therapeutics identification for fibrosis in renal allograft using integrative informatics approach
Oxidative Med. Cell. Longev. Li 9203716 2016 Maresin 1, a proresolving lipid mediator, mitigates carbon tetrachloride-induced liver injury in mice
Nutr. Rev. Libby 65 12 Pt 2 S140 2007 10.1301/nr.2007.dec.S140-S146 Inflammatory mechanisms: the molecular basis of inflammation and disease
Am. J. Pathol. Lin 173 6 1617 2008 10.2353/ajpath.2008.080433 Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney
J. Med. Chem. Liu 60 2 527 2017 10.1021/acs.jmedchem.6b00935 Idiopathic pulmonary fibrosis: current status, recent progress, and emerging targets
Diabetes Care Lopes-Virella 36 8 2317 2013 10.2337/dc12-2521 Baseline markers of inflammation are associated with progression to macroalbuminuria in type 1 diabetic subjects
Proc. Natl. Acad. Sci. U. S. A. Lopez-Vicario 112 2 536 2015 10.1073/pnas.1422590112 Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides
Nat. Med. Lovisa 21 9 998 2015 10.1038/nm.3902 Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis
J. Clin. investigation Lukiw 115 10 2774 2005 10.1172/JCI25420 A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease
Kidney Int. Mack 87 2 297 2015 10.1038/ki.2014.287 Origin of myofibroblasts and cellular events triggering fibrosis
Am. J. Pathol. Maderna 160 6 2275 2002 10.1016/S0002-9440(10)61175-3 Lipoxins induce actin reorganization in monocytes and macrophages but not in neutrophils: differential involvement of rho GTPases
Faseb J. Maderna 24 11 4240 2010 10.1096/fj.10-159913 FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis
Br. J. Pharmacol. Maderna 158 4 947 2009 10.1111/j.1476-5381.2009.00386.x Lipoxins: resolutionary road
Regul. Integr. Comp. physiology Manresa 307 12 R1369 2014 10.1152/ajpregu.00349.2014 Hypoxia-sensitive pathways in inflammation-driven fibrosis. American journal of physiology
J. Biol. Chem. Marcheselli 278 44 43807 2003 10.1074/jbc.M305841200 Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression
J. Immunol. Martins 182 9 5374 2009 10.4049/jimmunol.0802259 ATLa, an aspirin-triggered lipoxin A4 synthetic analog, prevents the inflammatory and fibrotic effects of bleomycin-induced pulmonary fibrosis
FASEB J. official Publ. Fed. Am. Soc. Exp. Biol. McMahon 16 13 1817 2002 Lipoxin, leukotriene, and PDGF receptors cross-talk to regulate mesangial cell proliferation
J. Biol. Chem. McMahon 275 36 27566 2000 10.1074/jbc.M001015200 Lipoxin A4 antagonizes the mitogenic effects of leukotriene D4 in human renal mesangial cells. Differential activation of MAP kinases through distinct receptors
J. Biol. Chem. McMahon 275 14 9901 2000 10.1074/jbc.275.14.9901 IHG-2, a mesangial cell gene induced by high glucose, is human gremlin. Regulation by extracellular glucose concentration, cyclic mechanical strain, and transforming growth factor-beta1
Nephrology Meng 12 6 325 2016 TGF-beta: the master regulator of fibrosis. Nature reviews
J. Biol. Chem. Mitchell 282 21 15606 2007 10.1074/jbc.M611004200 The Lipoxin A4 receptor is coupled to SHP-2 activation: implications for regulation of receptor tyrosine kinases
J. Am. Soc. Nephrol. Mitchell 13 10 2497 2002 10.1097/01.ASN.0000032417.73640.72 Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo
Immunology Mosser 8 12 958 2008 Exploring the full spectrum of macrophage activation. Nature reviews
J. Biol. Chem. Murphy 274 9 5830 1999 10.1074/jbc.274.9.5830 Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells
Nature Nathan 420 6917 846 2002 10.1038/nature01320 Points of control in inflammation
Lancet O'Connell 388 10048 983 2016 10.1016/S0140-6736(16)30826-1 Biopsy transcriptome expression profiling to identify kidney transplants at risk of chronic injury: a multicentre, prospective study
J. Med. Chem. O'Sullivan 50 24 5894 2007 10.1021/jm060270d Aromatic lipoxin A4 and lipoxin B4 analogues display potent biological activities
Proc. Natl. Acad. Sci. U. S. A. Pertwee 109 51 20781 2012 10.1073/pnas.1218529110 Lipoxin A4 is an allosteric endocannabinoid that strengthens anandamide-induced CB1 receptor activation
Bioorg. Med. Chem. Lett. Petasis 18 4 1382 2008 10.1016/j.bmcl.2008.01.013 Design and synthesis of benzo-lipoxin A4 analogs with enhanced stability and potent anti-inflammatory properties
Diabetes Pezzolesi 58 6 1403 2009 10.2337/db08-1514 Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes
Seminars Nephrol. Pezzolesi 30 2 126 2010 10.1016/j.semnephrol.2010.01.004 Insights to the genetics of diabetic nephropathy through a genome-wide association study of the GoKinD collection
Exp. Ther. Med. Qiu 7 6 1481 2014 10.3892/etm.2014.1641 Resolvin E1 reduces hepatic fibrosis in mice with Schistosoma japonicum infection
J. pathology Qu 228 4 506 2012 10.1002/path.4050 Resolvins E1 and D1 inhibit interstitial fibrosis in the obstructed kidney via inhibition of local fibroblast proliferation
Front. Pharmacol. Recio 7 526 2016 The potential therapeutic application of peptides and peptidomimetics in cardiovascular disease
J. Immunol. Reville 176 3 1878 2006 10.4049/jimmunol.176.3.1878 Lipoxin A4 redistributes myosin IIA and Cdc42 in macrophages: implications for phagocytosis of apoptotic leukocytes
Faseb J. Rius 28 2 836 2014 10.1096/fj.13-235614 Resolvin D1 primes the resolution process initiated by calorie restriction in obesity-induced steatohepatitis
Proc. Natl. Acad. Sci. U. S. A. Rock 108 52 E1475 2011 10.1073/pnas.1117988108 Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition
N. Engl. J. Med. Rockey 372 12 1138 2015 10.1056/NEJMra1300575 Fibrosis-a common pathway to organ injury and failure
Am. J. pathology Rodgers 167 3 683 2005 10.1016/S0002-9440(10)62043-3 Lipoxin A4 modifies platelet-derived growth factor-induced pro-fibrotic gene expression in human renal mesangial cells
Nephrology Ruggenenti 6 6 319 2010 The RAAS in the pathogenesis and treatment of diabetic nephropathy. Nature reviews
PLoS Genet. Sandholm 8 9 e1002921 2012 10.1371/journal.pgen.1002921 New susceptibility loci associated with kidney disease in type 1 diabetes
J. Am. Soc. Nephrol. Sandholm 28 2 557 2017 10.1681/ASN.2016020231 The genetic landscape of renal complications in type 1 diabetes
J. Immunol. Scannell 178 7 4595 2007 10.4049/jimmunol.178.7.4595 Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages
Diabetes Schmid 55 11 2993 2006 10.2337/db06-0477 Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy
Nature Serhan 510 7503 92 2014 10.1038/nature13479 Pro-resolving lipid mediators are leads for resolution physiology
Faseb J. Serhan 26 4 1755 2012 10.1096/fj.11-201442 Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain
Proc. Natl. Acad. Sci. U. S. A. Serhan 81 17 5335 1984 10.1073/pnas.81.17.5335 Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes
Prostaglandins Serhan 34 2 201 1987 10.1016/0090-6980(87)90243-7 Nomenclature of lipoxins and related compounds derived from arachidonic acid and eicosapentaenoic acid
Annu. Rev. pathology Serhan 3 279 2008 10.1146/annurev.pathmechdis.3.121806.151409 Anti-inflammatory and proresolving lipid mediators
Biochimica biophysica acta Simiele 1859 10 1252 2016 10.1016/j.bbagrm.2016.07.007 Epigenetic regulation of the formyl peptide receptor 2 gene
J. Immunol. Sodin-Semrl 164 5 2660 2000 10.4049/jimmunol.164.5.2660 Lipoxin A4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases
Cell metab. Spite 19 1 21 2014 10.1016/j.cmet.2013.10.006 Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases
J. Am. Soc. Nephrol. Sun 21 12 2069 2010 10.1681/ASN.2010060633 Epigenetic histone methylation modulates fibrotic gene expression
PloS one Sun 8 12 e84063 2013 10.1371/journal.pone.0084063 Endothelial dysfunction exacerbates renal interstitial fibrosis through enhancing fibroblast Smad3 linker phosphorylation in the mouse obstructed kidney
Science Tabas 339 6116 166 2013 10.1126/science.1230720 Anti-inflammatory therapy in chronic disease: challenges and opportunities
Nephrol. dialysis, Transplant. official Publ. Eur. Dialysis Transpl. Assoc. - Eur. Ren. Assoc. Takamiya 28 1 55 2013 10.1093/ndt/gfs387 Experimental diabetic nephropathy is accelerated in matrix metalloproteinase-2 knockout mice
J. Biol. Chem. Tang 292 10 4302 2017 10.1074/jbc.M116.773085 Transforming growth factor-beta (TGF-beta) directly activates the JAK1-STAT3 Axis to induce hepatic fibrosis in coordination with the SMAD pathway
Mediat. Inflamm. Tang 2017 2438247 2017 10.1155/2017/2438247 Maresin 1 mitigates high glucose-induced mouse glomerular mesangial cell injury by inhibiting inflammation and fibrosis
Hepatology Taura 51 3 1027 2010 10.1002/hep.23368 Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice
J. Clin. investigation Thannickal 124 11 4673 2014 10.1172/JCI74368 Fibrosis: ultimate and proximate causes
Expert Opin. Emerg. drugs Thomas 18 1 55 2013 10.1517/14728214.2013.762356 Emerging drugs for managing kidney disease in patients with diabetes
J. Immunol. Titos 187 10 5408 2011 10.4049/jimmunol.1100225 Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype
Comput. Struct. Biotechnol. J. Urbach 6 e201303018 2013 10.5936/csbj.201303018 The role of lipoxin A4 in cystic fibrosis lung disease
J. Am. Soc. Nephrol. Voelker 28 3 953 2017 10.1681/ASN.2015111230 Anti-TGF-beta1 antibody therapy in patients with diabetic nephropathy
Mol. Ther. J. Am. Soc. Gene Ther. Wang 24 7 1290 2016 10.1038/mt.2016.90 Mesenchymal stem cells deliver exogenous MicroRNA-let7c via exosomes to attenuate renal fibrosis
Ren. Physiol. Wang 299 5 F973 2010 10.1152/ajprenal.00216.2010 Mice lacking the matrix metalloproteinase-9 gene reduce renal interstitial fibrosis in obstructive nephropathy. American journal of physiology
Shock Wang 44 5 496 2015 10.1097/SHK.0000000000000446 Maresin 1 inhibits epithelial-to-mesenchymal transition in vitro and attenuates bleomycin induced lung fibrosis in vivo
Diabetes Woroniecka 60 9 2354 2011 10.2337/db10-1181 Transcriptome analysis of human diabetic kidney disease
FASEB J. official Publ. Fed. Am. Soc. Exp. Biol. Wu 30 6 2400 2016 Lipoxin A4 augments host defense in sepsis and reduces Pseudomonas aeruginosa virulence through quorum sensing inhibition
Br. J. Pharmacol. Wu 171 21 4927 2014 10.1111/bph.12816 Lipoxin A4 suppresses the development of endometriosis in an ALX receptor-dependent manner via the p38 MAPK pathway
Am. J. Pathol. Wu 174 1 115 2009 10.2353/ajpath.2009.080671 Elevated expressions of 15-lipoxygenase and lipoxin A4 in children with acute poststreptococcal glomerulonephritis
Prostagl. Leukot. Essent. Fat. acids Wu 76 3 173 2007 10.1016/j.plefa.2006.12.006 Signal transduction involved in protective effects of 15(R/S)-methyl- lipoxin A(4) on mesangioproliferative nephritis in rats
Kidney Int. Wu 69 2 248 2006 10.1038/sj.ki.5000025 Lipoxin A4 inhibits connective tissue growth factor-induced production of chemokines in rat mesangial cells
FEBS Lett. Yamamoto 492 3 247 2001 10.1016/S0014-5793(01)02258-X Cross-talk between IL-6 and TGF-beta signaling in hepatoma cells
Cytokine & growth factor Rev. Yanagita 16 3 309 2005 10.1016/j.cytogfr.2005.02.007 BMP antagonists: their roles in development and involvement in pathophysiology
Reproductive Biol. Endocrinol. RB&E Yang 13 95 2015 10.1186/s12958-015-0090-4 The involvement of osteopontin and matrix metalloproteinase- 9 in the migration of endometrial epithelial cells in patients with endometriosis
Physiol. Rep. Yatomi 3 12 2015 10.14814/phy2.12628 17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice
J. Am. Soc. Nephrol. Yoshikawa 18 1 58 2007 10.1681/ASN.2005111187 Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells
PloS one Zhang 8 6 e67471 2013 10.1371/journal.pone.0067471 Resolvin D1 protects podocytes in adriamycin-induced nephropathy through modulation of 14-3-3beta acetylation
ERJ open Res. Zheng 2 3 2016 10.1183/23120541.00079-2015 Lipoxin A4 promotes lung epithelial repair whilst inhibiting fibroblast proliferation
Hepatology Res. official J. Jpn. Soc. Hepatology Zhou 39 9 921 2009 10.1111/j.1872-034X.2009.00520.x Lipoxin A(4) inhibited hepatocyte growth factor-induced invasion of human hepatoma cells
Oxidative Med. Cell. Longev. Zong 6815727 2016 Lipoxin A4 attenuates cell invasion by inhibiting ROS/ERK/MMP pathway in pancreatic cancer
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.